Search
01/05/2024
Drainage setons for the management of sinus tracts in hidradenitis suppurativa.
Vilarrasa E, Camiña-Conforto G, Cabo F, Fernández-Vela J, Pousa M, Romaní J. Drainage setons for the management of sinus tracts in hidradenitis suppurativa.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(5)DOI:10.1016/j.jaad.2023.08.058. PMID:37634739. IF:11.800(Q1/1D).
01/05/2024
Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists
Vilarrasa, E, Rivera, R, Eiris, N, Carretero, G, de la Cueva, P, Carrascosa, JM. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists. Actas Dermo-Sifiliograficas. 2024; 115(5)DOI:10.1016/j.ad.2023.10.022. PMID:37925068. IF:(Q/D).
01/05/2024
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study
Pinter, A, Soliman, AM, Pivneva, I, Ghanbariamin, R, Yang, M, Truong, B, Puig, L, Lebwohl, M. Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and Therapy. 2024; 14(5)DOI:10.1007/s13555-024-01164-6. PMID:38727996. IF:4.200(Q1/1D).
01/05/2024
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan
Tada, Y, Soliman, AM, Ishii, K, Sakuma, R, Pinter, A, Davis, M, Nunag, D, Buessing, M, Puig, L, Imafuku, S. Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. EXPERIMENTAL DERMATOLOGY. 2024; 33(5)DOI:10.1111/exd.15067. PMID:38757460. IF:3.100(Q2/3D).
01/05/2024
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Gatica-Ortega, ME, Pastor-Nieto, MA, Giménez-Arnau, AM, Mercader-García, P, Sanz-Sánchez, T, Carrascosa-Carrillo, JM, Córdoba-Guijarro, S, Sánchez-Pérez, J, Silvestre, JF, Frutos, FJOD, Tous-Romero, F, Fernández-Redondo, V, Serra-Baldrich, E, Ruíz-González, I, Pérez, RG, Miquel-Miquel, J, Guillén, PSP, Hervella-García, M, Heras-Mendaza, F, Gómez-de-la-Fuente, E, Zaragoza-Ninet, V, Gilo, AS, Rodríguez-Serna, M, Melé-Ninot, G, Descalzo, MA, de-Vega, M, García-Doval, I, Borrego, L. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?. CONTACT DERMATITIS. 2024; 90(5)DOI:10.1111/cod.14520. PMID:38351475. IF:4.600(Q1/1D).
01/05/2024
SurLym trial: study protocol for a multicentre pragmatic randomised controlled trial on the added value of reconstructive lymphatic surgery to decongestive lymphatic therapy for the treatment of lymphoedema
Devoogdt, N, De Vrieze, T, Heroes, AK, Bechter-Hugl, B, Fieuws, S, Godderis, L, Segers, K, Maleux, G, Deltombe, T, Frippiat, J, Servaes, M, Berners, A, Fosseprez, P, Krug, B, Kayser, F, Falticeanu, A, Randon, C, Monten, C, Van Landuyt, K, De Pypere, B, Degraeve, L, Decorte, T, De Schryver, M, Van Besien, V, Devos, D, Suominen, S, Ayala, JM, Pons, G, Fourneau, I, Thomis, S. SurLym trial: study protocol for a multicentre pragmatic randomised controlled trial on the added value of reconstructive lymphatic surgery to decongestive lymphatic therapy for the treatment of lymphoedema. BMJ Open. 2024; 14(5)DOI:10.1136/bmjopen-2023-078114. PMID:38729754. IF:2.300(Q2/3D).